Vericiguat is a candidate for inclusion in guideline-directed medical therapy for heart failure with reduced ejection fraction, based on a meta-analysis showing an all-cause death reduction on top of ...
Severe alcohol-associated hepatitis (sAH) remains a highly lethal condition with limited therapeutic options. Characterized by rapid liver decompensation, sAH is often accompanied by acute kidney ...
Heart failure (HF) constitutes a significant disease burden in the USA. Its prevalence has doubled between 1990–2020, showing an ...